Related Experiment Video
Updated: Apr 12, 2026

Intratibial Osteosarcoma Cell Injection to Generate Orthotopic Osteosarcoma and Lung Metastasis Mouse Models
Published on: October 28, 2021
Let-7i inhibits the malignant phenotype of osteosarcoma cells by targeting Aurora-B
Guo Mei Zhang1, Xin Hua Long2, Jia Ming Liu2
1Department of Orthopedics, The Second Affiliated Hospital of Nanchang University, Nanchang, Jiangxi 330006, P.R. China.
Abstract:
Our previous study indicated that Aurora-B is involved in osteosarcoma (OS) cell invasion and metastasis; however, the mechanism underlying Aurora-B overexpression in OS remains unknown. In the present study, significantly downregulated let-7i expression in OS tissues and OS cells was observed compared with that in normal adjacent tumorous tissues and human osteoblast cell lines. Bioinformatic predictions have revealed a conserved binding site in a microRNA locus on Aurora‑B, suggesting the potential of let‑7i targeting the Aurora‑B gene. To validate this, a luciferase reporter assay was performed on OS cells. The results indicated that Aurora‑B is a likely to be a direct target negatively regulated by let‑7i. The expression of let‑7i in OS cells was restored by infection with let‑7i mimics. Results revealed that Aurora‑B mRNA and protein expression levels were significantly decreased. Furthermore, the proliferation, migration and invasion abilities of OS cells were significantly suppressed by infection with let‑7i mimics. Notably, the inhibitory effect of silencing Aurora‑B by LV‑shAurora‑B on cell proliferation, migratory and invasive ability was significantly lower than that by let‑7i mimics, which indicated that let‑7i inhibits cell malignant phenotypes partially by targeting Aurora‑B in OS cells. All data suggested that let‑7i may be a novel potential target for OS treatment.
Insights
This study reveals that let-7i microRNA targets Aurora-B, suppressing osteosarcoma cell invasion and proliferation. Restoring let-7i offers a potential therapeutic strategy for osteosarcoma treatment.
Area of Science:
- Oncology
- Molecular Biology
- Genetics
Background:
- Aurora-B kinase is implicated in osteosarcoma (OS) cell invasion and metastasis.
- The precise mechanism driving Aurora-B overexpression in OS remains unclear.
- let-7i microRNA expression is significantly downregulated in OS tissues and cells.
Purpose of the Study:
- To investigate the regulatory role of let-7i in Aurora-B expression within osteosarcoma.
- To explore the therapeutic potential of targeting the let-7i/Aurora-B axis in OS treatment.
Main Methods:
- Bioinformatic analysis to predict let-7i binding sites on Aurora-B mRNA.
- Luciferase reporter assays to validate direct targeting of Aurora-B by let-7i.
- In vitro experiments using let-7i mimics and Aurora-B silencing (LV-shAurora-B) in OS cells.
Main Results:
- let-7i directly targets and negatively regulates Aurora-B expression in OS cells.
- Restoration of let-7i significantly decreased Aurora-B mRNA and protein levels.
- let-7i mimics suppressed OS cell proliferation, migration, and invasion.
- let-7i's inhibitory effect on malignant phenotypes was partially mediated by Aurora-B downregulation.
Conclusions:
- let-7i acts as a tumor suppressor in osteosarcoma by targeting Aurora-B.
- The let-7i/Aurora-B pathway represents a promising novel therapeutic target for osteosarcoma.
More Related Videos
11:15A Preclinical Mouse Model of Osteosarcoma to Define the Extracellular Vesicle-mediated Communication Between Tumor and Mesenchymal Stem Cells
Published on: May 6, 2018
08:47Improved Visualization of Lung Metastases at Single Cell Resolution in Mice by Combined In-situ Perfusion of Lung Tissue and X-Gal Staining of lacZ-Tagged Tumor Cells
Published on: August 21, 2012
Related Concept Videos
MicroRNAs
MicroRNAs
mTOR Signaling and Cancer Progression
The mTOR pathway or the...
mTOR Signaling and Cancer Progression
PI3K/mTOR/AKT Signaling Pathway
Targeted Cancer Therapies
There are several types of targeted therapies against...